Skip to main content
. 2017 Aug 24;7:9371. doi: 10.1038/s41598-017-09907-6

Figure 2.

Figure 2

HG-treated cells undergoing the EndoMT secrete more exosomes than NG-treated GECs. (A) Exosomes extracted from GECs were observed by TEM. Magnification: ×150,000. (n = 4) (B) Protein blots of exosomes derived from the same number of NG- and HG-treated GECs using antibodies for calnexin, CD63 and CD9. In addition, the expression of calnexin in GECs was also examined by Western blotting. (n = 3 for each index) (C) Quantification of exosomes isolated from NG- and HG-treated GECs normalized by cell number. Compared to the NG-GEC-Exo group, HG-treated cells undergoing the EndoMT released a higher number of exosomes. The results are presented as the mean ± SD. *p < 0.05 versus NG-GEC-Exo group (Student’s t-test; n = 6). NG-GEC-Exo group, exosomes derived from NG-treated GECs; HG-GEC-Exo group, exosomes derived from HG-treated GECs.

HHS Vulnerability Disclosure